Sekar Kathiresan

Companies

• Maze Therapeutics, Inc.Board member Jan 30, 2025 to now¹
• Relay TherapeuticsBoard member Jul 27, 2022 to now²
• Verve Therapeutics, Inc.Board member Jun 16, 2021 to now³
• Verve Therapeutics, Inc.Chief executive officer Jun 16, 2021 to now³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• MTMaze Therapeutics, Inc. MAZE103,723 shares⁴$3.1M at $30.36Jan 30, 2025
• VTVerve Therapeutics, Inc.0 shares⁵Jul 25, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 25, 2025U 240,997 shares of Verve Therapeutics, Inc.⁵
• Jul 25, 2025U 110,997 shares of Verve Therapeutics, Inc.⁵
• Jul 25, 2025U 348,431 shares of Verve Therapeutics, Inc.⁵
• Apr 2, 2025Sold 9,822 shares at $4.15 of Verve Therapeutics, Inc.⁶
• Apr 1, 2025Exercised options 33,000 shares of Verve Therapeutics, Inc.⁶
• Dec 4, 2024Gift 30,000 shares of Verve Therapeutics, Inc.⁷
• Dec 4, 2024Gift 30,000 shares of Verve Therapeutics, Inc.⁷
• Jun 28, 2024Exercised options 30,000 shares at $2.87 of Verve Therapeutics, Inc.⁸
• Oct 3, 2022Sold 9,904 shares at $34.97 of Verve Therapeutics, Inc.⁹
• Oct 3, 2022Sold 11,185 shares at $34.13 of Verve Therapeutics, Inc.⁹
• Oct 3, 2022Sold 28,911 shares at $33.02 of Verve Therapeutics, Inc.⁹
• Oct 3, 2022Exercised options 50,000 shares at $1.39 of Verve Therapeutics, Inc.⁹
• Aug 10, 2022Sold 50,000 shares at $29.90 of Verve Therapeutics, Inc.¹⁰
• Aug 10, 2022Exercised options 50,000 shares at $1.39 of Verve Therapeutics, Inc.¹⁰
• Jul 19, 2022Sold 50,000 shares at $29.90 of Verve Therapeutics, Inc.¹¹
• Jul 19, 2022Exercised options 50,000 shares at $1.39 of Verve Therapeutics, Inc.¹¹
• Jul 7, 2022Gift 160,000 shares of Verve Therapeutics, Inc.¹²
• Jul 7, 2022Gift 160,000 shares of Verve Therapeutics, Inc.¹²
• Mar 18, 2022Exercised options 69,674 shares at $2.87 of Verve Therapeutics, Inc.¹³
• Jan 4, 2022Sold 1,870 shares at $39.90 of Verve Therapeutics, Inc.¹⁴
• Jan 4, 2022Exercised options 1,870 shares at $1.39 of Verve Therapeutics, Inc.¹⁴
• Dec 28, 2021Sold 6,693 shares at $39.90 of Verve Therapeutics, Inc.¹⁵
• Dec 28, 2021Exercised options 6,693 shares at $1.39 of Verve Therapeutics, Inc.¹⁵
• Dec 27, 2021Sold 770 shares at $42.21 of Verve Therapeutics, Inc.¹⁵
• Dec 27, 2021Sold 4,787 shares at $41.24 of Verve Therapeutics, Inc.¹⁵